Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment
Journal of Controlled Release · 2023-10 · 362 · 524-535
DOI: 10.1016/j.jconrel.2023.09.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-10. Verfasst von Shigao Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China; Department of Cell Biol…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Tumor Microenvironment, Receptors, Chimeric Antigen, Drug Carriers. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Science and Technology Planning Project of Shenzen Municipality, Science and Technology Development Fund, National Key Research and Development Program of China.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR)-modified natural killer (NK) cells are recognized as promising immunotherapeutic agents for cancer treatment. However, the efficacy and trafficking of CAR-NK cells in solid tumors are hindered by the complex barriers present in the tumor microenvironment (TME). We have developed a novel strategy that utilizes living CAR-NK cells as carriers to deliver anticancer drugs specifically to the tumor site. We also introduce a time-lapse method for evaluating the efficacy and tumor specificity of CAR-NK cells using a two-photon microscope in live mouse models and three-dimensional (3D) tissue slide cultures. Our results demonstrate that CAR-NK cells exhibit enhanced antitumor immunity when combined with photosensitive chemicals in both in vitro and in vivo tumor models. Additionally, we have successfully visualized the trafficking, infiltration, and accumulation of drug-loaded CAR-NK cells in deeply situated TME using non-invasive intravital two-photon microscopy. Our findings highlight that tumor infiltration of CAR-NK cells can be intravitally monitored through the two-photon microscope approach. In conclusion, our study demonstrates the successful integration of CAR-NK cells as drug carriers and paves the way for combined cellular and small-molecule therapies in cancer treatment. Furthermore, our 3D platform offers a valuable tool for assessing the behavior of CAR cells within solid tumors, facilitating the development and optimization of immunotherapeutic strategies with clinical imaging approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Translational Medicine, Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China; Department of Cell Biology of National Translational Science Center for Molecular Medicine an…
- Institute of Translational Medicine, Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, China; MoE Frontiers Science Center for Precision Oncology, University of Macau, Taipa, Macau SAR, C…
- MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Engineering Research Center for Synthetic Immunology, School of Basic Medical Sciences, Fudan…
- Geneleap Biotechnology LLC, Woburn, MA, USA. Electronic address: Dafeng.chu@luye.com.
Förderung
- Science and Technology Planning Project of Shenzen Municipality
- Science and Technology Development Fund
- National Key Research and Development Program of China
- Guangdong Provincial Natural Science Foundation
- University of Macau
Zitieren
APA
Huang, S., Xing, F., Dai, Y., Zhang, Z., Zhou, G., Yang, S., Liu, Y. C., Yuan, Z., Luo, K. Q., Ying, T., Chu, D., Liu, T. M., Deng, C. X., & Zhao, Q. (2023). Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment. Journal of Controlled Release, 362, 524-535. https://doi.org/10.1016/j.jconrel.2023.09.007
Vancouver
Huang S, Xing F, Dai Y, Zhang Z, Zhou G, Yang S, et al. Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment. Journal of Controlled Release. 2023;362:524-535. doi:10.1016/j.jconrel.2023.09.007
BibTeX
@article{Huang2023,
author = {Huang, Shigao and Xing, Fuqiang and Dai, Yeneng and Zhang, Zhiming and Zhou, Guangyu and Yang, Shuo and Liu, Yu-Cheng and Yuan, Zhen and Luo, Kathy Qian and Ying, Tianlei and Chu, Dafeng and Liu, Tzu-Ming and Deng, Chu-Xia and Zhao, Qi},
title = {Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment},
journal = {Journal of Controlled Release},
year = {2023},
volume = {362},
pages = {524--535},
doi = {10.1016/j.jconrel.2023.09.007}
}
EUVIMED